Latest news about Zydus Wellness
Zydus Wellness Expects Growth Resumption for Nycil and Glucon-D, Flags Positive Seasonal Outlook
Zydus Wellness
490.80
-10.50(-2.09%)
Company Performance:
View Company Insights1D-2.09%
1M-18.54%
6M+22.93%
1Y+23.19%
5Y+12.18%
More news about Zydus Wellness
05Aug 26
Zydus Wellness Latest Results: FY27 Tax Rate At 25%, 12%-15% Cash; FY28 Full Cash
Zydus Wellness projects a 25% tax rate for FY27, with cash tax outflow expected at 12% to 15% for the year. By FY28, the company anticipates the full 25% tax rate to be paid entirely in cash, indicating a normalisation of its tax cycle. Finance costs are expected to remain stable subject to the Euro benchmark rate holding steady, reflecting the company's sensitivity to international interest rate movements.
05Aug 26
Zydus Wellness appoints Diwanji as director despite institutional dissent
Zydus Wellness Limited concluded its 32nd AGM on August 4, 2026, approving the appointment of Apurva S. Diwanji as an Independent Director for five years and the re-election of Dr. Sharvil P. Patel. A ₹1.20 per share dividend was also declared. While promoters supported all resolutions unanimously, institutional investors opposed the board appointments, signaling governance concerns.
04Aug 26
Zydus Wellness Q1 Results: Investor call recording for Q1FY27 now available
Zydus Wellness Limited disclosed the availability of its Q1FY27 investor call recording on August 4, 2026. The audio, covering unaudited results for the quarter ended June 30, 2026, is hosted on the company website. The move complies with SEBI LODR Regulation 30 requirements for transparent investor communication.
21Jul 26
Zydus Wellness schedules Q1FY27 earnings call on Aug 4
Zydus Wellness announced an analyst call on August 4, 2026, at 15:00 IST to review unaudited Q1FY27 results. CEO Tarun Arora and CFO Umesh Parikh will lead the session.
13Jul 26
Zydus Wellness Files Integrated Annual Report for FY 2025-26 with Strong Revenue Growth
Zydus Wellness filed its Integrated Annual Report for FY 2025-26, reporting consolidated revenue from operations of ₹39,610 million (+46.2% YoY) and net profit of ₹1,972 million, driven by the landmark acquisition of UK-based Comfort Click Limited at GBP 242 million. The Board recommended a final dividend of ₹1.20 per equity share, and the 32nd AGM is scheduled for August 4, 2026. On the ESG front, total energy consumption stood at 5,13,542 GJ, Scope 1 & 2 emissions at 20,063 tCO2e, and the Company achieved an S&P Global CSA score of 84, ranking 3rd globally in the food products industry.
12Jul 26
Zydus Wellness fixes July 17 record date for FY26 dividend
Zydus Wellness Limited has fixed July 17, 2026 as the record date to determine shareholder eligibility for the dividend for the financial year ended March 31, 2026. The 32nd Annual General Meeting is scheduled for August 4, 2026, via video conferencing. Remote e-voting is available from July 31 to August 3, 2026, with a cut-off date of July 28, 2026. Physical shareholders must update KYC details by July 15, 2026, to ensure electronic dividend receipt.
11Jul 26
Zydus Wellness unit fined PLN 54,000 by Polish authority
Zydus Wellness Limited reported that its UK-based subsidiary, Comfort Click Limited, was fined PLN 54,000 by the Polish Tax authority for delays in filing Intrastat declarations. The penalty, valued at approximately ₹1.35 million, covers the period from January to September 2023. The company confirmed that the order has no material impact on its operations beyond the payment of the fine.
03Jul 26
Zydus Wellness accepts resignation of Head - Sales Lalit Ahuja
Zydus Wellness Limited accepted the resignation of Mr. Lalit Ahuja, Head – Sales (India & ISC), effective July 3, 2026. The disclosure was made to BSE Limited and National Stock Exchange of India Limited under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Mr. Ahuja cited the pursuit of better career opportunities as the reason for his resignation after a decade with the company.
01Jul 26
Zydus Wellness appoints Dr. Shyam Ramakrishnan as Chief Scientific Officer
Zydus Wellness Limited has appointed Dr. Shyam Ramakrishnan as Chief Scientific Officer effective July 1, 2026, based on the recommendation of the Nomination and Remuneration Committee. Dr. Ramakrishnan joins on a full-time contract with over 25 years of experience in translational science, clinical research, and innovation platform development. His previous leadership roles include positions at Hill's Pet Nutrition, The Himalaya Drug Company, ITC Ltd., and Amway across global markets.
01Jul 26
Zydus Wellness incorporates Dubai unit with AED 300,000 capital
Zydus Wellness International DMCC incorporated Zydus Wellness General Trading DWC-LLC in Dubai on June 30, 2026, with a share capital of AED 300,000. The wholly owned subsidiary aims to expand business in food, nutrition, and personal care sectors.
24Jun 26
Zydus Wellness incorporates Ireland unit for VMS expansion
Zydus Wellness International DMCC incorporated Zydus Wellness (EU) Limited in Ireland on June 23, 2026, with a share capital of €100 divided into 100 ordinary shares. The wholly owned step-down subsidiary, which has not yet commenced operations, aims to drive business expansion in the Vitamins, Minerals and Supplements sector. The transaction involved cash consideration and required no specific regulatory approvals.
23Jun 26
Zydus Wellness to hold non-deal roadshow in Hong Kong
Zydus Wellness Limited announced that its representatives will participate in a non-deal roadshow in Hong Kong on June 25, 2026, organized by Equirus Securities. The event will include one-on-one and group meetings with analysts and institutional investors to discuss business performance and strategy.
19Jun 26
Zydus Wellness promoter member buys 1,000 shares
Samar Babubhai Patel, a member of the Promoter Group, acquired 1,000 equity shares of Zydus Wellness on June 16, 2026, for ₹5,05,695.35. The transaction increased his total holding to 12,000 equity shares.
03Jun 26
Rupa Parekh acquires 4,000 Zydus Wellness shares worth ₹19.9 lakh
Rupa Nitinkumar Parekh, spouse of a designated person at Zydus Wellness Limited, acquired 4,000 equity shares on June 1, 2026, via an open market transaction worth ₹19,90,245.20. The disclosure, submitted by Company Secretary Nandish P. Joshi, confirmed the acquisition under SEBI regulations and noted no derivative trading activity.
03Jun 26
Zydus Wellness to attend ICICI conference on June 8
Zydus Wellness Limited will attend the ICICI Securities India Investor Conference on June 8, 2026, in Mumbai, to engage with analysts and institutional investors. The company filed the disclosure with BSE and NSE under Regulation 30 of the SEBI (LODR) Regulations, 2015.
28May 26
Zydus Wellness promoter acquires 10,000 shares via transmission
Samar Babubhai Patel, a member of the Promoter Group, acquired 10,000 equity shares of Zydus Wellness Limited through transmission from Late Jasodaben Babubhai Patel. The off-market transaction occurred on May 22, 2026, and was disclosed to BSE and NSE on May 26, 2026, in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015.
23May 26
Zydus Wellness FY26 Sales Jump 46.4% to ₹39,400 Million
Zydus Wellness Limited reported a 46.4% increase in consolidated net sales to ₹39,400 million for FY26, bolstered by the acquisition of Comfort Click Limited. Despite the topline growth, net profit declined to ₹1,972 million from ₹3,469 million in the previous year, impacted by higher operating costs, finance charges, and exceptional items totaling ₹408 million. The Board recommended a final dividend of ₹1.20 per share, while management maintained its guidance for EBITDA margins of 17-18% in the coming years, excluding the Comfort Click business.
18May 26
Zydus Wellness fixes July 17 record date for ₹1.20 dividend
Zydus Wellness Limited has fixed July 17, 2026, as the record date for a final dividend of ₹1.20 per share, pending shareholder approval at the AGM on August 4, 2026. The board also appointed Mr. Apurva S. Diwanji as an Additional Independent Director for a five-year term.
10May 26
Zydus Wellness Schedules Q4FY26 Analyst & Investor Conference Call for May 18, 2026
Zydus Wellness Limited has scheduled a teleconference call for analysts and institutional investors on May 18, 2026, at 4:00 p.m. IST, following the announcement of audited financial results for the quarter and financial year ended March 31, 2026. Facilitated by ICICI Securities, the call will feature Dr. Sharvil Patel (Chairman), Mr. Ganesh Nayak (Non-Executive Director), Mr. Tarun Arora (CEO), and Mr. Umesh Parikh (CFO), with dial-in access available across India, Singapore, Hong Kong, UK, and USA.
05May 26
Zydus Wellness Schedules Board Meeting on May 18, 2026 to Consider FY26 Financial Results and Dividend
Zydus Wellness Limited has notified stock exchanges of a Board of Directors meeting to be held on May 18, 2026, to approve audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. The board will also consider recommending a final dividend, if any, for FY26, subject to shareholder approval. In line with SEBI's Insider Trading Regulations, the trading window will remain closed until May 20, 2026, and reopen from May 21, 2026 for all Directors and Designated Persons.
11Apr 26
Zydus Wellness Limited Submits Q4FY26 SEBI Compliance Certificate for Dematerialization Process
Zydus Wellness Limited filed its Q4FY26 compliance certificate under SEBI Regulation 74(5) on April 11, 2026, confirming proper dematerialization procedures for equity shares during the quarter ended March 31, 2026. The company's registrar MUFG Intime India Private Limited validated that all dematerialization activities were conducted within regulatory timelines with appropriate verification processes.
07Apr 26
Zydus Wellness Clarifies Significant Volume Movement in Equity Shares to BSE
Zydus Wellness Limited responded to BSE surveillance inquiry about significant equity volume increases, confirming compliance with SEBI disclosure regulations. The company stated no undisclosed events exist that could impact share movement and attributed volume surge to market-driven factors. The wellness company reaffirmed its commitment to ongoing regulatory compliance under SEBI Listing Obligations.
04Apr 26
Zydus Wellness Subsidiary Comfort Click Limited Receives EUR 19,472.57 VAT Penalty
Zydus Wellness Limited has disclosed that its UK-based subsidiary Comfort Click Limited received a EUR 19,472.57 VAT penalty from Spanish Tax Authority for alleged unpaid VAT in Q1 2021 due to incorrect VAT payment mapping. The subsidiary plans to appeal the order, believing it has strong merits, with the company stating no current impact on operations.
31Mar 26
Zydus Wellness Opens Special Window for Physical Securities Transfer and Dematerialisation
Zydus Wellness Limited has opened a special window facility from February 5, 2026 to February 4, 2027 for transfer and dematerialisation of physical securities purchased before April 1, 2019, following SEBI Circular dated January 30, 2026. Securities transferred during this period will be credited in demat mode only and subject to one-year lock-in. Eligible investors must submit required documents to RTA MUFG Intime India Private Limited before February 4, 2027.
30Mar 26
Zydus Wellness Subsidiary Receives ₹6.30 Million GST Penalty Order from CGST Commissionerate
Zydus Wellness Limited's wholly owned subsidiary, Zydus Wellness Products Limited, has received a GST penalty order of ₹6.30 million along with applicable interest from the CGST Commissionerate in Ghaziabad for alleged less reversal of input tax credit covering financial years 2019-20 and 2020-21. The company received the order on March 29, 2026, and has stated that it will assess the next course of action as the order is appealable. The company maintains that there is no immediate impact on its financial or operational activities, with any impact limited to the final tax liability that may be determined along with interest and penalty.
18Mar 26
Zydus Wellness Designated Person Acquires 1,500 Equity Shares Worth ₹6.04 Lakh
Zydus Wellness Limited disclosed that designated person Rinesh Gajjar acquired 1,500 equity shares worth ₹6,04,443.15 from the open market between March 12-13, 2026. The transaction was executed on NSE and disclosed on March 16, 2026, under SEBI insider trading regulations. Post-acquisition, Gajjar's shareholding remains at 0.00% of the company's total share capital.
18Mar 26
Zydus Wellness Releases Revised Investor Presentation for March 2026 Conference
Zydus Wellness Limited has released a revised investor presentation for its March 18-19, 2026 conference, highlighting robust financial metrics with gross margins of 47.50%-63.30% and strong brand portfolio performance. The company serves over 70 million families through 2.80 million stores with key brands like Complan achieving 4.10% market share and RiteBite Max Protein expanding to nine international markets.
09Mar 26
Zydus Wellness Designated Persons Acquire 2,037 Equity Shares Worth ₹7.78 Lakh
Zydus Wellness Limited disclosed equity share acquisitions by three designated persons totaling 2,037 shares worth ₹7.78 lakh. Vineet Shrivastava acquired 787 shares for ₹3.01 lakh, Yatin Desai bought 500 shares for ₹1.90 lakh, and Rajat Bhargava purchased 750 shares for ₹2.87 lakh between March 2-6, 2026.
03Mar 26
Zydus Wellness CFO Umesh V. Parikh Acquires 250 Equity Shares Worth ₹95,019.00
Zydus Wellness CFO Umesh V. Parikh acquired 250 equity shares worth ₹95,019.00 from BSE on March 2, 2026, increasing his total holding from 18,755 to 19,005 shares. The company disclosed this transaction under SEBI PIT Regulations on March 3, 2026, fulfilling mandatory compliance requirements for designated person share acquisitions.
02Mar 26
Zydus Wellness Designated Person Acquires 507 Equity Shares Worth ₹1.99 Lakh
Zydus Wellness Limited disclosed that Designated Person Vineet Shrivastava acquired 507 equity shares worth ₹1,99,504.50 from the open market on NSE on February 26, 2026. The transaction was reported under SEBI PIT Regulations, with the company filing Form B with stock exchanges on March 2, 2026. Despite the acquisition, Shrivastava's shareholding percentage remains at 0.00% of total equity.
16Feb 26
Zydus Wellness CEO Tarun Arora Acquires 4,000 Equity Shares Worth ₹16.26 Lakh
Zydus Wellness Limited disclosed that CEO and Whole Time Director Tarun Arora acquired 4,000 equity shares valued at ₹16,25,585 through open market transactions on NSE between February 12-13, 2026. This acquisition increased his total shareholding from 11,000 to 15,000 shares, though his percentage holding remains at 0.00% due to the company's large share capital. The disclosure was filed under SEBI PIT Regulations by Company Secretary Nandish P. Joshi.
09Feb 26
Zydus Wellness Q3FY26 Earnings Call: Management Discusses Strong Growth Trajectory
Zydus Wellness conducted its Q3FY26 earnings conference call, revealing strong revenue growth of 113.7% and EBITDA expansion to 6.3%. The company's acquisitions, particularly RiteBite and Comfort Click, are performing well with double-digit growth trajectories and margin improvements.
21Jan 26
Zydus Wellness Limited Schedules Board Meeting on February 3, 2026 for Q3FY26 Financial Results
Zydus Wellness Limited has scheduled its Board of Directors meeting for February 3, 2026, to approve Q3FY26 unaudited financial results for the quarter and nine months ended December 31, 2025. The company has notified BSE and NSE in compliance with SEBI regulations, with trading window restrictions in place until February 5, 2026, for Directors and Designated Persons.
10Jan 26
Gujarat High Court Grants Ad-Interim Relief to Zydus Wellness Subsidiary on ₹56.33 Crore GST Demand
Gujarat High Court granted ad-interim relief to Zydus Wellness Products Limited on January 9, 2026, restraining proceedings on a ₹56.33 crore GST demand issued by DGGI Surat. The demand covers the pre-acquisition period before January 30, 2019, with liability fully indemnified by Heinz Italia S.P.A. The subsidiary had challenged the September 30, 2025 Order-in-Original through a writ petition under Article 226 of the Constitution.
01Jan 26
Zydus Wellness Limited Clarifies Recent Volume Surge in Equity Shares to BSE
Zydus Wellness Limited responded to BSE surveillance inquiry on January 1, 2026, regarding significant volume increases in its equity shares. The company clarified that it has no undisclosed events affecting share behavior, attributing the volume surge to market forces, and reaffirmed its commitment to SEBI regulatory compliance.
05Nov 25
Zydus Wellness Reports Q2 Net Loss Despite Revenue Growth
Zydus Wellness Limited reported a 31% increase in Q2 net sales to 6,429.00 million rupees, but faced profitability challenges with a net loss of 528.00 million rupees. The company incurred exceptional costs of 342.00 million rupees related to acquisitions. Despite challenges, H1 net sales grew by 12.8% to 15,006.00 million rupees. Factors affecting performance included seasonal impacts, GST 2.0 implementation, and acquisition costs. The company maintained market leadership in key product categories and made strategic moves by acquiring Comfort Click Limited and Naturell (India) Pvt Ltd.
29Oct 25
Zydus Wellness Subsidiary Faces ₹563.3 Million Tax Demand
Zydus Wellness Limited's subsidiary, Zydus Wellness Products Limited (ZWPL), has received a GST demand of ₹563.30 million plus interest and penalties from the Directorate General of Goods and Services Tax Intelligence. The demand relates to alleged GST payable on intellectual property rights acquisition from Heinz Italia S.P.A. by Heinz India Private Limited, which merged with ZWPL. The tax liability pertains to the pre-acquisition period before January 30, 2019. ZWPL is evaluating appeal options and maintains a strong position on the case's merits. Zydus Wellness states the liability is fully indemnified by Heinz Italia S.P.A. and foresees no immediate financial impact.
Industry Peers
Nestle
Britannia IndustriesZydus Wellness
Bikaji Foods International
Bombay Burmah Trading
Mrs. Bectors Food
Gopal Snacks
ADF Foods
Prataap Snacks
Tasty Bite Eatables
1,477.10
(+1.31%)
5,365.00
(-3.30%)
490.80
(-2.09%)
605.75
(-0.21%)
1,427.40
(-0.60%)
254.83
(-1.24%)
282.30
(-0.16%)
267.60
(+0.09%)
1,179.30
(+0.37%)
10,135.50
(+0.31%)
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
